脂蛋白a与同型半胱氨酸联合测定对冠心病早期诊断的临床价值  

Clinical value of determination of lipoprotein A and homocysteine in early diagnosis of coronary heart disease

作　　者：马凌云[1] MA Ling-yun(Taixing People's Hospital,Taixing 225400,China)

机构地区：[1]江苏省泰兴市人民医院,江苏泰兴225400

出　　处：《临床医药文献电子杂志》2020年第91期2-3,5,共3页Electronic Journal of Clinical Medical Literature

摘　　要：目的探究对冠心病患者实施早期诊断中脂蛋白a、同型半胱氨酸联合测定的价值。方法随机将2018年12月至2020年12月我院40例冠心病患者作为实验组,同期将院内40例体检中心健康体检人员作为对照组。针对两组患者分别测定脂蛋白a、同型半胱氨酸水平。结果实验组患者脂蛋白a水平为(28.03±8.02)mg/dL、同型半胱氨酸水平为(17.76±5.33)μmol/L,与对照组相比,P<0.05。结论冠心病患者血清脂蛋白a水平、同型半胱氨酸水平与健康人群相比均相对较高,因而在日常生活中定期对以上两项指标进行检测,更有利于疾病的早期诊断和预防。Objective To explore the value of the combined determination of lipoprotein A and homocysteine in the early diagnosis of coronary heart disease.Methods a total of 40 patients with coronary heart disease in our hospital from December 2018 to December 2020 were randomly selected as the experimental group,and 40 healthy people in the physical examination center were randomly selected as the control group during the same period.Lipoprotein A and homocysteine levels were measured in the two groups.Results The levels of lipoprotein A and homocysteine in the experimental group were(28.03±8.02)mg/dL and(17.76±5.33)mol/L(P<0.05),respectively,compared with the control group.Conclusion Serum lipoprotein A level and homocysteine level in patients with coronary heart disease are relatively high compared with healthy people.Therefore,regular detection of the above two indicators in daily life is more conducive to the early diagnosis and prevention of the disease.

关 键 词：脂蛋白A 同型半胱氨酸 冠心病 早期诊断 临床价值 

分 类 号：R44[医药卫生—诊断学]